|
Oh dear. I typed out a reply then lost it by clicking on "back." I will try again.
I am Her2++ on the IHC and have a score of 8.7 on the FISH.
The onc agreed to give me Taxol with Herceptin because of recent trials that have shown good results when using the two drugs concurrently. I would receive the low doses of Taxol which would be given with Herceptin once a week for 12 weeks.
A quote from Dr. Marine Piccart, Head of the Medicine Department at the Jules Bordet Institute in Brussels and lead investigator of the HERA study, helped me with my decision.
In a Monday, May 16, 2005 news release regarding the HERA trial, she said, "In the advanced breast cancer setting, Herceptin has already demonstrated that it prolongs patients' lives. To see such impressive results with Herceptin in early-stage breast cancer, already at the interim analysis, is a major breakthrough in the treatment of this aggressive disease. These results now add to the growing body of evidence that Herceptin should be considered the foundation of care for HER2-positive breast cancer patients, regardless of the stage of their disease."
It is worth a try, in my opinion. Thank the Lord for trials and the masses of individuals world wide who have contributed to our knowledge in the on- going fight with cancer.
Many blessings, Barbara2
|